PRTK
Paratek Pharmaceuticals, Inc.
PRTK
PRTK
Delisted
PRTK was delisted on the 20th of September, 2023.
63 hedge funds and large institutions have $59M invested in Paratek Pharmaceuticals, Inc. in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 22 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
18% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 22
61% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 18
Holders
63
Holding in Top 10
1
Calls
$172K
Puts
$34K
Top Buyers
| 1 | +$6.05M | |
| 2 | +$2.62M | |
| 3 | +$2.2M | |
| 4 |
EP
Eversept Partners
New York
|
+$1.62M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$602K |
Top Sellers
| 1 | -$3.76M | |
| 2 | -$1.27M | |
| 3 | -$926K | |
| 4 |
TMC
Trellus Management Company
Delray Beach,
Florida
|
-$427K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$380K |